Načítá se...
PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells
The non-receptor tyrosine kinase, PTK6/BRK, is highly expressed in multiple tumor types, including prostate, ovarian, and breast cancers, and regulates oncogenic phenotypes such as proliferation, migration, and survival. PTK6 inhibition also overcomes targeted therapy resistance of HER2+ breast canc...
Uloženo v:
| Vydáno v: | NPJ Breast Cancer |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5694002/ https://ncbi.nlm.nih.gov/pubmed/29167821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-017-0047-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|